[1]
2024. Technical comment on: Trottmann M, et al. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data. Swiss Medical Weekly. 154, 10 (Oct. 2024), 3704. DOI:https://doi.org/10.57187/s.3704.